News

Yahoo Finance27d
Merck Animal Health Receives EU CVMP Positive Opinion for NUMELVI™ (atinvicitinib) Tablets for Dogs - Yahoo Finance
RAHWAY, N.J., June 12, 2025--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
Yahoo Finance27d
Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate - Yahoo Finance
RAHWAY, N.J., June 12, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 Phase 3 clinical trial evaluating the safety ...
MarketWatch1mon
Merck Cholesterol Drug Hits Main Goals in Two Phase 3 Studies
The Rahway, N.J., drugmaker said enlicitide showed statistically significant and clinically meaningful greater reductions in low-density lipoprotein cholesterol, or LDL-C, compared to placebo and ...
Business Wire16d
Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension ... - Business Wire
Media Contacts: Julie Cunningham (617) 519-6264 Courtney Ronaldo (908) 442-5695 Investor Contacts: Peter Dannenbaum (732) 594-1579 Steven Graziano (732) 594-1583 ...
STAT29d
Readout Newsletter: 23andMe, Merck, Recursion, Avidity, Insmed - STAT
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...
Nasdaq15d
Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention - Nasdaq
Media Contacts: Robert Josephson [email protected] Julie Cunningham [email protected] Investor Contacts: Peter Dannenbaum (732) 594-1579 Steven Graziano (732) 594-1583 ...
Business Wire21d
IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer - Business Wire
BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)--The first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab ...
NBC New York1mon
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - NBC New York
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca By Annika Kim Constantino, CNBC • Published June 9, 2025 • Updated on June 9, 2025 at 4:15 pm ...
Nasdaq27d
Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate
Merck, known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 Phase 3 clinical trial evaluating the safety, immunogenicity and efficacy of a single ...
Pharm Exec29d
FDA Approves Merck’s Enflonsia to Prevent Respiratory Syncytial Virus
FDA Approves Merck’s Enflonsia for RSV Prevention in Infants: Enflonsia (clesrovimab-cfor) is a long-acting monoclonal antibody approved to prevent respiratory syncytial virus (RSV) lower respiratory ...
pharmaphorum3d
Merck turns to cardiovascular pipeline for its post-Keytruda future
During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...